000 | 02001 a2200541 4500 | ||
---|---|---|---|
005 | 20250515223040.0 | ||
264 | 0 | _c20110518 | |
008 | 201105s 0 0 eng d | ||
022 | _a1532-8422 | ||
024 | 7 |
_a10.1053/j.jvca.2010.02.007 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLotz, Christopher | |
245 | 0 | 0 |
_aActivation of adenosine-monophosphate-activated protein kinase abolishes desflurane-induced preconditioning against myocardial infarction in vivo. _h[electronic resource] |
260 |
_bJournal of cardiothoracic and vascular anesthesia _cFeb 2011 |
||
300 |
_a66-71 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAMP-Activated Protein Kinases _xmetabolism |
650 | 0 | 4 |
_aAminoimidazole Carboxamide _xanalogs & derivatives |
650 | 0 | 4 |
_aAnesthetics, Inhalation _xtherapeutic use |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBody Temperature _xdrug effects |
650 | 0 | 4 | _aCardiotonic Agents |
650 | 0 | 4 | _aDesflurane |
650 | 0 | 4 |
_aElectrocardiography _xdrug effects |
650 | 0 | 4 | _aEnzyme Activation |
650 | 0 | 4 |
_aGlycogen _xmetabolism |
650 | 0 | 4 |
_aHemodynamics _xdrug effects |
650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
650 | 0 | 4 | _aImmunoprecipitation |
650 | 0 | 4 | _aIschemic Preconditioning, Myocardial |
650 | 0 | 4 |
_aIsoflurane _xanalogs & derivatives |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMyocardial Infarction _xpathology |
650 | 0 | 4 |
_aMyocardium _xenzymology |
650 | 0 | 4 | _aRabbits |
650 | 0 | 4 |
_aRibonucleotides _xpharmacology |
700 | 1 | _aFisslthaler, Beate | |
700 | 1 | _aRedel, Andreas | |
700 | 1 | _aSmul, Thorsten M | |
700 | 1 | _aStumpner, Jan | |
700 | 1 | _aPociej, Joanna | |
700 | 1 | _aRoewer, Norbert | |
700 | 1 | _aFleming, Ingrid | |
700 | 1 | _aKehl, Franz | |
700 | 1 | _aLange, Markus | |
773 | 0 |
_tJournal of cardiothoracic and vascular anesthesia _gvol. 25 _gno. 1 _gp. 66-71 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1053/j.jvca.2010.02.007 _zAvailable from publisher's website |
999 |
_c19812066 _d19812066 |